Bimekizumab is effective for active psoriatic arthritis in biologic-naïve adults
1. Significantly more patients in the bimekizumab group reached ACR50 at week 16 compared to the placebo. 2. Fungal infections...
1. Significantly more patients in the bimekizumab group reached ACR50 at week 16 compared to the placebo. 2. Fungal infections...
1. Risk of hospital admission was lower in the ferric derisomaltose group versus usual care. 2. Treatment-related adverse events were...
1. Pregnancy loss was reported among 8.0% of patients in the monofilament suture group and 7.6% of patients in the...
1. Bivalirudin during percutaneous coronary intervention plus high-dose infusion after demonstrated decreased all-cause mortality compared to heparin monotherapy. 2. Risk...
1. Risk of venous thromboembolism in the antepartum and postpartum period was comparable between the intermediate- and low-dose low-molecular weight...
1. There was no significant difference between groups in terms of rate of caesarean delivery, caesarean delivery for failure to...
1. More intensive blood pressure targets were associated with poor functional outcome at 90 days, neurological deterioration, and major disability...
1. At 24 months, treatment success rate was numerically greater in the shorter-regimen group versus conventional therapy, satisfying the noninferiority...
1. The primary composite cardiovascular endpoint was similar among patients in the evening and morning dose groups. 2. Self-reported adverse...
1. Povidone-iodine and chlorhexidine were comparable in terms of surgical site infections. 2. 16% of patients in both groups required...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.